Upstream Bio Inc. (UPB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
10.44
-0.33 (-3.06%)
At close: Jan 24, 2025, 3:59 PM
10.39
-0.43%
After-hours Jan 24, 2025, 04:00 PM EST
Company Description
No Company description available at the moment.
Upstream Bio Inc.
Country | n/a |
IPO Date | n/a |
Industry | n/a |
Sector | n/a |
Employees | 38 |
CEO | Dr. E. Rand Sutherland M.D., M.P.H., MPH |
Contact Details
Address: No Address available No city data available, | |
Website | n/a |
Stock Details
Ticker Symbol | n/a |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | n/a |
CUSIP Number | n/a |
ISIN Number | US91678A1079 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Dr. E. Rand Sutherland M.D., M.P.H., MPH | Chief Executive Officer & Director |
Michael Paul Gray CPA, MBA | Chief Financial Officer & Chief Operating Officer |
Aaron Deykin M.D. | Chief Medical Officer and Head of Research & Development |
Allison Ambrose | General Counsel |
Dr. Adam Houghton M.B.A., Ph.D. | Chief Business Officer |
Dr. Sumathi Sivapalasingam M.D. | Vice President & Head of Clinical Development |
Fang Xie Ph.D. | Vice President & Head of Biometrics |
Lisa Fiering | Senior Vice President of People & Culture |
Mersedeh Miraliakbari Pharm.D. | Senior Vice President of Regulatory Affairs & Quality |
Parika Petaipimol M.S. | Head of Technical Operations |